Author： Shibata Toshihiko Yamamoto Fumio Suehiro Shigefumi Kinoshita Hiroaki
Publisher： Springer Publishing Company
ISSN： 0920-3206
Source： Cardiovascular Drugs and Therapy, Vol.11, Iss.4, 1997-09, pp. : 547-556
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Pantos C. Mourouzis I. Delbruyere M. Malliopoulou V. Tzeis S. Cokkinos D.D. Nikitas N. Carageorgiou H. Varonos D. Cokkinos D. Nisato D.
European Journal of Pharmacology, Vol. 444, Iss. 3, 2002-05 ,pp. :
Access to resources
Recommend
Tipranavir in the Protease Inhibitors Arena
By Vergani Barbara Rusconi Stefano
Drugs in R&D, Vol. 11, Iss. 4, 2011-12 ,pp. :
Heterocyclic HIV-Protease Inhibitors
Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. :
By Kuhnert Maren Diederich Wibke E.
PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. :
Protease Inhibitors in the Clinic
Medicinal Chemistry, Vol. 1, Iss. 1, 2005-01 ,pp. :